Notice ID: c3d7f4ebcb9c454e8d093a814fe5cceeAward NoticeAwarded
Sequencing Service to Support Gene Therapy Research
Awarded on September 22, 2022. Full description on SAM.gov.
Awarded tounder 75F40122P00530 (source: SAM.gov award notice)• $20.0K
Overview
- Posted
- September 29, 2022
- Notice type
- Award Notice
- NAICS
- 325413: In-Vitro Diagnostic Substance Manufacturing
- Agency
- Department of Health and Human Services
Notice details
- Place of performance
- 72450, MD, 20903
- Last updated
- Dec 4, 2025
- Award date
- Sep 22, 2022
- Award amount (SAM.gov award notice)
- $20.0K
Identifiers
- Solicitation number
- FDA-RFQ-1255498
- Notice ID
- c3d7f4ebcb9c454e8d093a814fe5ccee
- Award number (PIID)
- 75F40122P00530
Description
09/07/2022: Amendment No. 1 issued responding to questions received. Questions & Answers enclosed as Attachment No: 3. ******************************************************************************************************************************************** This requirement is to provide sequencing services on purified human genomic DNA samples. Please see enclosed RFQ for full details.
Award Overview
Award Number
75F40122P00530
Award Amount (SAM.gov award notice)
$20.0K
Award Date
Sep 22, 2022
Awardee
Awardee UEI
SG1RJE5JG1K6
Original Solicitation
Notice ID: c3d7f4ebcb9c454e8d093a814fe5ccee
Posted Date: Sep 29, 2022
Original Response Deadline: Not specified
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
FDA-RFQ-1255498- Combined Synopsis
- Awarded
This opportunity has been awarded.
- 2×Combined SynopsisAug 26, 2022
Sequencing Service to Support Gene Therapy Research
- AwardedCurrentSep 29, 2022
Sequencing Service to Support Gene Therapy Research
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
FDA-RFQ-1255498
Archive Date
Oct 7, 2022
Office Address
Beltsville, MD, 20705